logo

ESP / FR / GB / GR / IT / CH / PT

Assessment of the Impact of the COVID-19 Pandemic on People with Rheumatic Diseases in Europe

¿Por qué REUMAVID?

  • El objetivo de REUMAVID es evaluar el impacto de la pandemia COVID-19 y el confinamiento en la actividad de la enfermedad, el acceso a la atención sanitaria y al tratamiento, los servicios de apoyo, el bienestar y la salud mental de los pacientes reumáticos.
  • Capturar la perspectiva de los pacientes con el fin de abordar las necesidades no cubiertas sobre cuestiones importantes para los pacientes reumáticos.
  • Generar información basada en la evidencia para concienciar sobre el impacto de la pandemia COVID-19.
  • Proporcionar a las asociaciones datos y evidencia que permita defender los derechos de los pacientes reumáticos ante crisis, como la pandemia COVID-19.
  • Identificar los miedos y esperanzas de los pacientes durante la pandemia COVID-19.

Reumavid in numbers

1
Patients recruited across europe
1
countries
1
Patient Organizations
1
Scientific Conferences

Had their rheumatologist appointment cancelled

58%

Had their rheumatologist appointment cancelled

58%

Increased smoking

25%

Raised their alcohol consumption

18%

Were unable to continue exercising

46%

Were at risk of anxiety

57%

Were at risk of depression

46%

Our
News

Participating Patient Organizations

REUMAVID is a project conducted by the Health & Territory Research (HTR) group of the University of Seville (Spain)

Supported by

© 2021 All Rights Reserved

Centro de preferencias de privacidad

      Necessary

      Advertising

      Analytics

      Other

      This website uses its own and third-party cookies to analyze and improve your browsing experience. By continuing to browse, we understand that you accept their use.    More information
      Privacidad